Mangalam Drugs & Organics Limited (BOM:532637)
27.00
-0.50 (-1.82%)
At close: Jul 28, 2026
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 427.36 million as of July 28, 2026. Its market cap has decreased by -69.72% in one year.
Market Cap
427.36M
Enterprise Value
1.55B
Revenue
2.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.00
ChartMarket Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 427.36M, an increase of 99.36%. That is a compound annual growth rate of 3.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 427.36M | -2.14% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asston Pharmaceuticals | 546.87M |
| Biofil Chemicals and Pharmaceuticals | 520.44M |
| ANG Lifesciences India | 469.31M |
| Shelter Pharma | 452.91M |
| Vista Pharmaceuticals | 447.48M |
| Rajnish Wellness | 416.29M |
| Parmax Pharma | 384.72M |
| Sandu Pharmaceuticals | 379.58M |